From Presidential Orders to Rule Proposals by various agencies, this tool helps you keep track of the documents as they are published to the Federal Register to keep up with what's happening on Capital Hill.
Results per page:
Showing 10 of 10000 documents
Showing 10 of 10000 documents
Type: Rule
Doc Number: 2026-14195
Published: 2026-07-14
Agencies:
We, the U.S. Fish and Wildlife Service (FWS) and the National Marine Fisheries Service (NMFS; collectively referred to as the "Services") rescind the regulatory definition of "harm" in our Endangered Species Act (ESA or the Act) regulations. This rescission removes the regulatory definition of "harm" from the Code of Federal Regulations (CFR) in Title 50 parts 17 and 222.
Type: Proposed Rule
Doc Number: 2026-14193
Published: 2026-07-14
Agencies:
The Pipeline and Hazardous Materials Safety Administration is seeking comment on a Petition for Declaratory Order (Petition) requesting PHMSA issue an order regarding requirements for baseline integrity assessments.
Type: Proposed Rule
Doc Number: 2026-14161
Published: 2026-07-14
Agencies:
On May 15, 2026, FRA published an NPRM proposing to rescind FRA's final rule requiring the certification of signal employees. By this notice, FRA is extending the NPRM's comment period by an additional 30 days.
Type: Proposed Rule
Doc Number: 2026-14160
Published: 2026-07-14
Agencies:
On May 15, 2026, FRA published an NPRM proposing to rescind FRA's May 21, 2024 final rule requiring the certification of dispatchers. By this notice, FRA is extending the NPRM's comment period by 30 days.
Type: Notice
Doc Number: 2026-14159
Published: 2026-07-14
Agencies:
In accordance with the Paperwork Reduction Act (PRA) of 1995, the Department is proposing an extension without change of a currently approved information collection request (ICR).
Type: Notice
Doc Number: 2026-14158
Published: 2026-07-14
Agencies:
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry titled "Psychedelic Drugs: Considerations for Clinical Investigations." Because interest in the therapeutic potential of psychedelic drugs has been increasing and designing clinical trials to evaluate these compounds presents unique challenges, FDA developed the draft guidance to present foundational aspects for sponsors to consider. This final guidance provides general considerations for sponsors developing psychedelic drugs for the treatment of medical conditions (e.g., psychiatric disorders, substance use disorders) and discusses recommendations for clinical investigations psychedelic drugs. This guidance finalizes the draft guidance of the same title issued on June 26, 2023.
Type: Notice
Doc Number: 2026-14157
Published: 2026-07-14
Agencies:
In accordance with the procedures governing the application for, and the processing of, special permits from the Department of Transportation's Hazardous Material Regulations, notice is hereby given that the Office of Hazardous Materials Safety has received the application described herein.
Type: Notice
Doc Number: 2026-14156
Published: 2026-07-14
Agencies:
In accordance with the procedures governing the application for, and the processing of, special permits from the Department of Transportation's Hazardous Material Regulations, notice is hereby given that the Office of Hazardous Materials Safety has granted or denied the application described herein.
Type: Notice
Doc Number: 2026-14155
Published: 2026-07-14
Agencies:
The Food and Drug Administration (FDA, the Agency, or we) is announcing a public hearing on the potential future therapeutic use of psychedelic drugs. In collaboration with federal partners, FDA is holding this public hearing to obtain feedback and perspectives on issues associated with the potential future therapeutic use of drug products containing a psychedelic drug substance in supervised and supportive settings.
Type: Notice
Doc Number: 2026-14154
Published: 2026-07-14
Agencies:
In accordance with the procedures governing the application for, and the processing of, special permits from the Department of Transportation's Hazardous Material Regulations, notice is hereby given that the Office of Hazardous Materials Safety has received the application described herein.
Results per page:
Powered by the Federal Register API